LSL-KrasG12D was conditionally activated in all of the pancreatic cancer cell lines (Fig. 5A), indicating that Kras activation is required for pancreatic tumorigenesis in these mice. This evidence concerns the gene KRAS and familial pancreatic carcinoma.